DCF — NEW ULM MEDICAL CENTER
Enterprise Value: $30.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$30.6M
Enterprise Value
$5.7M
PV of Cash Flows
$24.9M
PV of Terminal Value
$40.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $132.4M | $6.2M | 5.0% | $-0.1M | $-0.1M |
| Year 2 | $136.4M | $7.8M | 6.0% | $0.9M | $0.7M |
| Year 3 | $140.5M | $9.4M | 7.0% | $2.0M | $1.5M |
| Year 4 | $144.7M | $10.4M | 7.0% | $2.6M | $1.8M |
| Year 5 | $149.0M | $11.1M | 7.0% | $2.9M | $1.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $30.6M. Terminal value accounts for 81% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$128.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.04188762232351147
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5